Lv3
372 积分 2023-10-10 加入
脑胶质瘤靶向和免疫治疗专家共识(2025版)
3天前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-2010, a novel anti-MASP-2 antibody, in healthy volunteers: a randomized, double-blind, placebo-controlled phase 1 study
2个月前
已完结
The Landscape of IgA Nephropathy Treatment Strategy: A Pharmacological Overview
3个月前
已完结
Current trial landscape of IgA nephropathy therapy
3个月前
已完结
Interpretation of the clinical practice guidelines for adult patients with IgA nephropathy and IgA vasculitis-associated nephritis in China (2025)
4个月前
已完结
The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045
5个月前
已完结
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends
5个月前
已完结
Multiple myeloma
5个月前
已完结
Multiple myeloma
5个月前
已完结
前列腺癌全程管理专家共识（2025版）
6个月前
已完结
皖公网安备34019202002308
